Publikationen, an denen er mitarbeitet Remedios Gómez Sanz (5)

2022

  1. Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer

    Cellular Immunology, Vol. 382

2021

  1. A reliable and standardizable differential PCR and qPCR methodology assesses HER2 gene amplification in gastric cancer

    Biology, Vol. 10, Núm. 6

  2. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

    Frontiers in Immunology, Vol. 12

  3. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease

    Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 2, pp. 774-783

2020

  1. Defects at the posttranscriptional level account for the low TCRζ chain expression detected in gastric cancer independently of caspase-3 activity

    Journal of Immunology Research, Vol. 2020